open access
Aktualizacja opinii ekspertów Sekcji Krążenia Płucnego Polskiego Towarzystwa Kardiologicznego dotycząca badań przesiewowych w kierunku CTEPH u chorych po przebytej ostrej zatorowości płucnej
Affiliations- Klinika Chorób Wewnętrznych i Kardiologii z Centrum Diagnostyki i Leczenia Żylnej Choroby Zakrzepowo Zatorowej, Warszawski Uniwersytet Medyczny, Warszawa
- Klinika Krążenia Płucnego, Chorób Zakrzepowo-Zatorowych i Kardiologii, Centrum Medyczne Kształcenia Podyplomowego w Warszawie, Europejskie Centrum Zdrowia, Otwock
- Ośrodek Chorób Krążenia Płucnego, Klinika Chorób Serca i Naczyń, Instytut Kardiologii, Collegium Medicum, Uniwersytet Jagielloński, Kraków
- Oddział Kliniczny Chorób Serca i Naczyń z Pododdziałem Intensywnego Nadzoru Kardiologicznego, Krakowski Szpital Specjalistyczny im. Jana Pawła II, Kraków
- Oddział Kardiologii i Intensywnego Nadzoru Kardiologicznego, Wojewódzki Szpital Specjalistyczny im. Stefana Kardynała Wyszyńskiego SPZOZ, Lublin
- Katedra i I Klinika Kardiologii, Uniwersytet Medyczny w Łodzi
- Zakład Medycyny Populacyjnej i Prewencji Chorób Cywilizacyjnych, Uniwersytet Medyczny w Białymstoku
- Klinika Kardiologii z Oddziałem Intensywnego Nadzoru Kardiologicznego, Uniwersytecki Szpital Kliniczny, Białystok
- I Katedra i Klinika Kardiologii, Wydział Lekarski w Katowicach, Śląski Uniwersytet Medyczny, Katowice
- European Reference Network for Rare, Low Prevalence, or Complex Diseases of the Heart (ERN GUARD Heart)
- I Klinika Kardiologii, Uniwersytet Medyczny im. Karola Marcinkowskiego, Poznań
- Klinika Kardiochirurgii, Szpital Medicover, Warszawa
- Klinika Kardiologii, Uniwersytecki Szpital Kliniczny, Instytut Chorób Serca, Wrocław
open access
Abstract
Abstract
About this articleTitle
Aktualizacja opinii ekspertów Sekcji Krążenia Płucnego Polskiego Towarzystwa Kardiologicznego dotycząca badań przesiewowych w kierunku CTEPH u chorych po przebytej ostrej zatorowości płucnej
Journal
Kardiologia Polska (Polish Heart Journal)
Issue
Vol 80, Supp. III (2022): Zeszyty Edukacyjne 3/2022
Article type
Opinie i stanowiska ekspertów
Pages
133-142
Page views
33
Article views/downloads
22
Authors
Michał Ciurzyński
Marcin Kurzyna
Grzegorz Kopeć
Piotr Błaszczak
Łukasz Chrzanowski
Karol Kamiński
Katarzyna Mizia-Stec
Tatiana Mularek-Kubzdela
Andrzej Biederman
Dariusz Zieliński
Piotr Pruszczyk
Adam Torbicki
Ewa Mroczek
References (32)- Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020; 41(4): 543–603.
- Delcroix M, Torbicki A, Gopalan D, et al. ERS statement on chronic thromboembolic pulmonary hypertension. Eur Respir J. 2021; 57(6).
- Kopeć G, Dzikowska-Diduch O, Mroczek E, et al. Characteristics and outcomes of patients with chronic thromboembolic pulmonary hypertension in the era of modern therapeutic approaches: data from the Polish multicenter registry (BNP-PL). Ther Adv Chronic Dis. 2021; 12: 20406223211002961.
- Klok FA, Ageno W, Ay C, et al. Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory Society. Eur Heart J. 2022; 43(3): 183–189.
- Klok FA, van der Hulle T, den Exter PL, et al. The post-PE syndrome: a new concept for chronic complications of pulmonary embolism. Blood Rev. 2014; 28(6): 221–226.
- Kahn SR, Comerota AJ, Cushman M, et al. The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2014; 130(18): 1636–1661.
- Klok FA, Barco S, Konstantinides SV, et al. Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry. Eur Respir J. 2018; 52(6).
- Ende-Verhaar YM, van den Hout WB, Bogaard HJ, et al. Healthcare utilization in chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. J Thromb Haemost. 2018; 16(11): 2168–2174.
- Boon GJ, Ende-Verhaar YM, Beenen LFM, et al. Prediction of chronic thromboembolic pulmonary hypertension with standardised evaluation of initial computed tomography pulmonary angiography performed for suspected acute pulmonary embolism. Eur Radiol. 2022; 32(4): 2178–2187.
- Ribeiro A, Lindmarker P, Johnsson H, et al. Pulmonary embolism: one-year follow-up with echocardiography doppler and five-year survival analysis. Circulation. 1999; 99(10): 1325–1330.
- Tunariu N, Gibbs SJR, Win Z, et al. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med. 2007; 48(5): 680–684.
- Gopalan D, Blanchard D, Auger WR. Diagnostic evaluation of chronic thromboembolic pulmonary hypertension. Ann Am Thorac Soc. 2016; 13(Suppl 3): S222–S239.
- Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2021; 42(6): 563–645.
- Kurzyna M, Araszkiewicz A, Błaszczak P, et al. Summary of recommendations for the haemodynamic and angiographic assessment of the pulmonary circulation. Joint statement of the Polish Cardiac Society's Working Group on Pulmonary Circulation and Association of Cardiovascular Interventions. Kardiol Pol. 2015; 73(1): 63–68.
- Hoeper MM, Lee SH, Voswinckel R, et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol. 2006; 48(12): 2546–2552.
- Kopeć G, Kurzyna M, Mroczek E, et al. Database of pulmonary hypertension in the polish population (BNP‑PL): design of the registry. Kardiol Pol. 2019; 77(10): 972–974.
- Siennicka A, Darocha S, Banaszkiewicz M, et al. Treatment of chronic thromboembolic pulmonary hypertension in a multidisciplinary team. Ther Adv Respir Dis. 2019; 13: 1753466619891529.
- Guth S, D'Armini AM, Delcroix M, et al. Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry. ERJ Open Res. 2021; 7(3).
- Kerr KM, Elliott CG, Chin K, et al. Results from the United States chronic thromboembolic pulmonary hypertension registry: enrollment characteristics and 1-year follow-up. Chest. 2021; 160(5): 1822–1831.
- Wieteska M, Biederman A, Kurzyna M, et al. Outcome of medically versus surgically treated patients with chronic thromboembolic pulmonary hypertension. Clin Appl Thromb Hemost. 2016; 22(1): 92–99.
- Darocha S, Roik M, Kopeć G, et al. Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: a multicentre registry. EuroIntervention. 2022; 17(13): 1104–1111.
- Bunclark K, Newnham M, Chiu YD, et al. A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension. J Thromb Haemost. 2020; 18(1): 114–122.
- Humbert M, Simonneau G, Pittrow D, et al. Safety of riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension with concomitant novel oral anticoagulants or vitamin k antagonist use: data from the EXPERT registry. Am J Respir Crit Care Med. 2020; 201: A6043.
- Ghofrani HA, D'Armini AM, Grimminger F, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med. 2013; 369(4): 319–329.
- Sadushi-Kolici R, Jansa P, Kopec G, et al. Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial. Lancet Respir Med. 2019; 7(3): 239–248.
- Montani D, Savale L, Beurnier A, et al. Multidisciplinary approach for post-acute COVID-19 syndrome: time to break down the walls. Eur Respir J. 2021; 58(1).
- Roncon L, Zuin M, Barco S, et al. Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis. Eur J Intern Med. 2020; 82: 29–37.
- Pellicori P, Doolub G, Wong CM, et al. COVID-19 and its cardiovascular effects: a systematic review of prevalence studies. Cochrane Database Syst Rev. 2021; 3(3): CD013879.
- Miró Ò, Jiménez S, Mebazaa A, et al. Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome. Eur Heart J. 2021; 42(33): 3127–3142.
- Newman J, Boubriak I, Jenkins D, et al. Rising COVID-19 related acute pulmonary emboli but falling national chronic thromboembolic pulmonary hypertension referrals from a large national dataset. ERJ Open Res. 2021; 7(4).
- Belge C, Quarck R, Godinas L, et al. COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey. ERJ Open Res. 2020; 6(4).
- Wieteska-Miłek M, Szmit S, Florczyk M, et al. Fear of COVID-19, Anxiety and Depression in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the Pandemic. J Clin Med. 2021; 10(18).
